Jeffrey Balser
Vice Chancellor for Health Affairs

  1. Selective gamma-ketoaldehyde scavengers protect Nav1.5 from oxidant-induced inactivation. Nakajima T, Davies SS, Matafonova E, Potet F, Amarnath V, Tallman KA, Serwa RA, Porter NA, Balser JR, Kupershmidt S, Roberts LJ (2010) J Mol Cell Cardiol 48(2): 352-9
    › Primary publication · 19962379 (PubMed) · PMC2818591 (PubMed Central)
  2. Robust replication of genotype-phenotype associations across multiple diseases in an electronic medical record. Ritchie MD, Denny JC, Crawford DC, Ramirez AH, Weiner JB, Pulley JM, Basford MA, Brown-Gentry K, Balser JR, Masys DR, Haines JL, Roden DM (2010) Am J Hum Genet 86(4): 560-72
    › Primary publication · 20362271 (PubMed) · PMC2850440 (PubMed Central)
  3. Beyond Flexner: a new model for continuous learning in the health professions. Miller BM, Moore DE, Stead WW, Balser JR (2010) Acad Med 85(2): 266-72
    › Primary publication · 20107354 (PubMed)
  4. Solution NMR structure of the C-terminal EF-hand domain of human cardiac sodium channel NaV1.5. Chagot B, Potet F, Balser JR, Chazin WJ (2009) J Biol Chem 284(10): 6436-45
    › Primary publication · 19074138 (PubMed) · PMC2649110 (PubMed Central)
  5. Novel molecular determinants in the pore region of sodium channels regulate local anesthetic binding. Yamagishi T, Xiong W, Kondratiev A, Vélez P, Méndez-Fitzwilliam A, Balser JR, Marbán E, Tomaselli GF (2009) Mol Pharmacol 76(4): 861-71
    › Primary publication · 19620257 (PubMed) · PMC2769053 (PubMed Central)
  6. Functional Interactions between Distinct Sodium Channel Cytoplasmic Domains through the Action of Calmodulin. Potet F, Chagot B, Anghelescu M, Viswanathan PC, Stepanovic SZ, Kupershmidt S, Chazin WJ, Balser JR (2009) J Biol Chem 284(13): 8846-54
    › Primary publication · 19171938 (PubMed) · PMC2659242 (PubMed Central)